Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%NCT03519386Glaukos CorporationPhase 3Completed2022-04-05Actual
Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung CancerNCT03520686IBRXPhase 3Terminated2025-10-13Actual
Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed GlioblastomaNCT03522298Kazia Therapeutics LimitedPhase 2Completed2023-03-30Actual
Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's DiseaseNCT03533257AMLXPhase 2Completed2020-10-22Actual
Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEFNCT03541603TENXPhase 2Completed2020-04-07Actual
Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]NCT03555422KPTIPhase 3Completed2022-01-22Actual
D-PLEX 302: Efficacy and Safety of D-PLEX in the Prevention of Sternal Infection Post Cardiac SurgeryNCT03558984PYPDPhase 3Terminated2022-10-24Actual
Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRPNCT03562832Allarity TherapeuticsPhase 2Completed2024-04-01Actual
CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)NCT03566043RGNXPhase 2, Phase 3Active not recruiting2023-11-27Actual
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)NCT03568331Vanda PharmaceuticalsPhase 3Completed2019-12-27Actual
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).NCT03573401BFRIPhase 3Active not recruiting2024-03-19Actual
A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative DiseaseNCT03575052ACADPhase 3Completed2022-05-06Actual
Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576NCT03588026AKARI TherapeuticsPhase 3Completed2020-09-03Actual
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the KneeNCT03588975Vericel CorporationPhase 3Recruiting2030-02Estimated
Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD TreatmentNCT03597503SUPNPhase 3Terminated2020-01-22Actual
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDINCT03602261OPKPhase 2Terminated2021-02-24Actual
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeNCT03604198Corcept TherapeuticsPhase 2Active not recruiting2026-12Estimated
Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)NCT03606590NVCRPhase 2Completed2021-01-14Actual
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) NephropathyNCT03608033Omeros CorporationPhase 3Terminated2024-01-12Actual
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular PsoriasisNCT03619902Vanda PharmaceuticalsPhase 2Completed2021-01-20Actual
Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative DiseaseNCT03623321ACADPhase 3Completed2023-05-05Actual
Open-Label Rollover Study of Levosimendan in PH-HFpEF PatientsNCT03624010TENXPhase 2Completed2023-04-25Actual
D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional InfectionNCT03633123PYPDPhase 2Completed2019-09-06Actual
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar PustulosisNCT03633396Vanda PharmaceuticalsPhase 2Completed2021-04-23Actual
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHDNCT03638466SUPNPhase 2Terminated2019-11-07Actual
Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)NCT03643107Allarity TherapeuticsPhase 2Completed2021-10-01Actual
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid TumorsNCT03645928IOVAPhase 2Terminated2026-02-20Actual
Long Term Extension Trial of SetmelanotideNCT03651765RYTMPhase 2, Phase 3Completed2025-01-09Actual
A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)NCT03665038SUPNPhase 3Completed2021-01-08Actual
Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary AspergillosisNCT03672292SCYXPhase 2Terminated2023-03-27Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.